Exai Bio Funding & Investors
Palo Alto, CA
Exai Bio is a next-generation liquid biospy company. Exai bio proprietary RNA and artificial intelligence-based liquid biopsy platform deliver clinical insights into cancer biology to enable the earliest, most accurate diagnosis of cancer.
exai.bioTotal Amount Raised: $67,500,000
Exai Bio Funding Rounds
Series A
$67,500,000
Series A Investors
Two Sigma VenturesSection 32Casdin Capital
Funding info provided by Diffbot.